5-Formamidoimidazole-4-carboxamide ribotide
Appearance
(Redirected from FAICAR)
![]() | |
Names | |
---|---|
IUPAC name
(1R)-1,4-Anhydro-1-(4-carbamoyl-5-formamido-1H-imidazol-1-yl)-D-ribitol 5-(dihydrogen phosphate)
| |
Systematic IUPAC name
[(2R,3S,4R,5R)-5-(4-Carbamoyl-5-formamido-1H-imidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | |
Other names
5-Formamidoimidazole-4-carboxamide ribonucleotide,
FAICAR | |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
MeSH | 5-formamidoimidazole-4-carboxamide+ribotide |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C10H15N4O9P | |
Molar mass | 366.223 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
5-Formamidoimidazole-4-carboxamide ribotide (or FAICAR) is an intermediate in the formation of purines. It is formed by the enzyme AICAR transformylase from AICAR and 10-formyltetrahydrofolate.[1]
References
[edit]- ^ USA.gov (2005-06-24). "FAICAR C10H15N4O9P". PubChem. National Center for Biotechnology Information. Retrieved 2022-07-09.